FJU-C4, a New 2-Pyridone Compound, Attenuates Lipopolysaccharide-Induced Systemic Inflammation via p38MAPK and NF-κB in Mice

Despite advances in antibiotic therapy and intensive care, the mortality caused by systemic inflammatory response syndrome and severe sepsis remains high. The use of anti-inflammatory agents to attenuate inflammatory response during acute systemic inflammatory reactions may improve survival rates. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jung-Sen, Jung, Fang, Yang, Shih-Hsing, Chou, Shang-Shing P., Huang, Jhih-Liang, Lu, Chang-Lin, Huang, Guan-Lin, Yang, Pan-Chyr, Lin, Jau-Chen, Jow, Guey-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871526/
https://www.ncbi.nlm.nih.gov/pubmed/24376600
http://dx.doi.org/10.1371/journal.pone.0082877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871526/
https://www.ncbi.nlm.nih.gov/pubmed/24376600
http://dx.doi.org/10.1371/journal.pone.0082877

Ejemplares similares